Mednow Inc. Acquires London Pharmacare Inc. and Liver Care Canada Inc.
February 23, 2022
Mednow Inc. completed the acquisitions of London Pharmacare Inc. and Liver Care Canada Inc., expanding its specialty pharmacy and clinical services footprint. The transactions (related-party in part) are expected to increase Mednow's patient base, add specialty physician relationships and integrate the targets into Mednow's technology and fulfillment operations.
- Buyers
- Mednow Inc.
- Targets
- London Pharmacare Inc., Liver Care Canada Inc.
- Sellers
- Shareholders of London Pharmacare Inc., Shareholders of Liver Care Canada Inc., Amir Ali Reyhany-Bozorg, Felipe Campusano
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Mednow Inc. Acquires Mednow Pharmacy Inc. (Mednow West)
October 26, 2021
Healthcare Services
Mednow Inc. completed the acquisition of all issued and outstanding shares of Mednow Pharmacy Inc. ("Mednow West"), consolidating the British Columbia online pharmacy into its national virtual-pharmacy platform. The purchase involved an aggregate cash payment of approximately $74,000 and conversion of about $908,000 owed by Mednow West into a convertible promissory note; the move supports Mednow's geographic expansion across Canada.
-
Mednow Inc. Acquires Infusicare Canada Inc.
December 13, 2021
Healthcare Services
Mednow Inc. (TSXV:MNOW) has completed the acquisition of Infusicare Canada Inc. for C$1.85 million in cash. The specialty pharmacy, which generated C$9.3 million in revenue in its last fiscal year, will be integrated into Mednow’s digital pharmacy platform to expand its specialty and biologic drug offerings.
-
Mednow Inc. Acquires Mednow Pharmacy Inc. (Mednow East)
April 1, 2022
Healthcare Services
Mednow Inc. (TSXV:MNOW) has completed the previously announced acquisition of all issued and outstanding voting shares of Mednow Pharmacy Inc. ("Mednow East") for approximately C$65,578 in cash and by converting approximately C$1,374,422 of intercompany debt into a non‑interest bearing convertible promissory note. Mednow East will be consolidated into Mednow's operations, the existing pharmacy agreement between the entities will be terminated, and the acquisition supports Mednow’s plan to expand its national presence and digital-first pharmacy services across Canada.
-
Mednow Acquires Medvisit (Doctors Housecall Service)
August 6, 2021
Healthcare Services
Mednow Inc. acquired 2716725 Ontario Inc. doing business as Medvisit for $1.32 million in cash at closing plus an earn-out of up to $680,000 tied to profitability. Medvisit, Canada’s largest doctor house-call service with a network of over 100 doctors, ~30,000 patient home visits per year and a ~400,000 patient database, will be integrated with Mednow’s virtual pharmacy and telehealth services to expand in‑home care capabilities in Ontario (GTA).
-
Mednow Invests in Life Support Mental Health Inc. and Signs LOI to Acquire Ontario Medical Operation
July 12, 2021
Healthcare Services
Mednow Inc. invested $500,000 for a 9% equity stake in Life Support Mental Health Inc. (LSMH), with the option to increase its ownership to ~18% through additional milestone-based tranches. The company also signed a non-binding letter of intent to acquire an unnamed medical operation based in Ontario to expand complementary services on its virtual pharmacy and telemedicine platform.
-
Medicure Inc. Acquires Marley Drug, Inc.
December 15, 2020
Healthcare Services
Medicure Inc., through its wholly-owned U.S. subsidiary Medicure Pharma Inc., agreed to acquire 100% of Marley Drug, Inc., a specialty mail-order pharmacy based in North Carolina, for an upfront USD $6.3 million plus contingent payments. Marley serves over 30,000 customers nationwide, generated approximately $7.0 million of revenue and more than $1.7 million of EBITDA for the 12 months ended October 31, 2020, and the acquisition expands Medicure's direct-to-patient distribution and specialty pharmacy capabilities in the United States.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.